Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

MRIC Insider Trading

ClearPoint Neuro, Inc. | Surgical & Medical Instruments & Apparatus

Comprehensive Trading Performance Summary

The investment history of corporate insiders at ClearPoint Neuro, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Surgical & Medical Instruments & Apparatus sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2018-09-26 00:23 2018-09-25 BURNETT JOSEPH MICHAEL Director, Officer - President and CEO BUY $1.25 25,000 $31,250 256,004 +10.8%
2018-08-24 23:05 2018-08-22 BURNETT JOSEPH MICHAEL Director, Officer - President and CEO BUY $1.57 12,137 $19,037 238,504 +5.4%
2018-05-23 23:05 2018-05-21 BURNETT JOSEPH MICHAEL Director, Officer - President and CEO BUY $2.39 7,500 $17,903 557,500 +1.4%
2017-05-30 23:24 2017-05-26 Jenkins Kimble L. Director BUY $0.00 7,500 $0 34,638 +27.6%
2017-05-30 23:22 2017-05-26 Grillo Francis P Director, Officer - CHIEF EXECUTIVE OFFICER BUY $0.00 12,500 $0 44,588 +39.0%
2016-09-08 01:39 2016-09-02 Rooke Andrew K. Director BUY $0.00 10,000 $0 10,000 +100.0%
2016-09-08 01:36 2016-09-02 Grillo Francis P Director, Officer - CHIEF EXECUTIVE OFFICER BUY $0.00 20,000 $0 32,088 +165.5%
2015-12-22 00:55 2015-12-18 Grillo Francis P Director, Officer - CHIEF EXECUTIVE OFFICER/PRES BUY $0.00 308,071 $0 308,071 +100.0%
2015-12-22 00:54 2015-12-18 KOOB CHARLES E Director BUY $0.00 154,035 $0 736,931 +26.4%
2015-12-22 00:52 2015-12-18 Rooke Andrew K. Director BUY $0.00 154,035 $0 465,117 +49.5%
2015-12-22 00:50 2015-12-18 Richards Timothy T. Director BUY $0.00 77,017 $0 110,005 +233.5%
2014-12-24 19:57 2014-12-24 Sainz Maria Director BUY $0.00 23,310 $0 32,895 +243.2%
2014-09-16 00:02 2014-09-12 SPENCER JOHN N JR Director BUY $1.18 16,000 $18,880 7,500 +100.0%
2014-08-14 15:31 2014-08-13 SPENCER JOHN N JR Director BUY $1.00 3,500 $3,500 86,582 +4.2%
2013-08-20 23:32 2013-08-19 PIETRANGELO MICHAEL Director BUY $1.27 100,000 $127,000 451,296 +28.5%
2013-06-12 23:34 2013-06-11 PIETRANGELO MICHAEL Director BUY $1.10 41,855 $46,041 339,024 +14.1%
2013-05-15 03:08 2013-05-13 SPENCER JOHN N JR Director BUY $1.32 1,500 $1,980 1,500 +100.0%
2013-03-25 23:39 2013-03-22 Conway Bruce C. Director BUY $1.48 2,500 $3,700 17,500 +16.7%
2013-03-21 23:04 2013-03-19 Conway Bruce C. Director BUY $1.50 2,500 $3,748 252,500 +1.0%
2013-03-18 23:39 2013-03-14 Conway Bruce C. Director BUY $1.50 32,665 $48,837 21,500 +100.0%
2013-03-15 00:55 2013-03-13 Conway Bruce C. Director BUY $1.50 2,000 $3,000 2,030,933 +0.1%
2013-03-13 00:30 2013-03-11 Conway Bruce C. Director BUY $1.54 28,550 $43,904 10,000 +100.0%
2013-01-26 01:23 2013-01-25 Malernee James K. Jr. Director BUY $0.00 100,000 $0 290,659 +52.4%
2013-01-26 01:17 2013-01-25 Conway Bruce C. Director BUY $0.00 100,000 $0 2,023,883 +5.2%
2013-01-26 01:19 2013-01-25 SPENCER JOHN N JR Director BUY $0.00 10,000 $0 56,433 +21.5%
2013-01-26 01:21 2013-01-25 PIETRANGELO MICHAEL Director BUY $0.00 125,000 $0 297,169 +72.6%
2012-09-18 23:03 2012-09-14 Conway Bruce C. Director BUY $2.19 4,000 $8,770 17,000 +30.8%
2012-09-14 23:09 2012-09-12 Conway Bruce C. Director BUY $2.05 18,750 $38,443 16,500 +100.0%
2012-09-12 23:19 2012-09-10 Conway Bruce C. Director BUY $2.14 22,500 $48,085 25,000 +900.0%
2012-09-07 23:49 2012-09-06 Conway Bruce C. Director BUY $2.23 4,600 $10,273 11,500 +66.7%
2012-08-29 00:43 2012-08-27 Conway Bruce C. Director BUY $2.39 20,900 $49,920 9,900 +100.0%
2012-08-24 23:36 2012-08-22 Conway Bruce C. Director BUY $2.43 14,500 $35,303 8,000 +100.0%
2012-08-24 23:11 2012-08-20 Conway Bruce C. Director BUY $2.38 8,000 $19,010 6,500 +100.0%
2012-08-22 00:28 2012-08-20 Conway Bruce C. Director BUY $2.40 12,500 $29,970 6,500 +100.0%
2012-08-16 23:26 2012-08-15 Conway Bruce C. Director BUY $2.47 31,950 $78,792 5,000 +100.0%
2012-07-06 23:39 2012-07-03 Malernee James K. Jr. Director BUY $0.00 45,454 $0 182,326 +33.2%
2012-07-06 23:26 2012-07-03 Conway Bruce C. Director BUY $0.00 100,000 $0 1,913,568 +5.5%
2012-07-07 00:03 2012-07-03 SPENCER JOHN N JR Director BUY $0.00 9,981 $0 27,787 +56.1%
2012-07-06 23:49 2012-07-03 PIETRANGELO MICHAEL Director BUY $0.00 90,000 $0 163,263 +122.8%
2012-06-15 23:32 2012-06-14 Conway Bruce C. Director BUY $0.95 3,000 $2,860 1,000 +100.0%
2012-06-15 23:43 2012-06-14 PIETRANGELO MICHAEL Director BUY $0.95 5,000 $4,750 73,263 +7.3%
2012-06-15 00:29 2012-06-13 Conway Bruce C. Director BUY $1.10 10,000 $10,950 10,000 +100.0%
2012-06-13 18:56 2012-06-12 Conway Bruce C. Director BUY $1.20 2,250 $2,700 1,500 +100.0%
2012-06-07 00:59 2012-06-06 PIETRANGELO MICHAEL Director BUY $1.46 10,000 $14,580 68,263 +17.2%
2012-05-29 22:49 2012-05-25 Conway Bruce C. Director BUY $0.75 3,748 $2,811 1,813,568 +0.2%
2012-05-22 19:21 2012-05-21 PIETRANGELO MICHAEL Director BUY $0.76 10,000 $7,569 58,263 +20.7%
SHOW ENTRIES

How to Interpret $MRIC Trades

Not every insider transaction in ClearPoint Neuro, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $MRIC shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for MRIC

Insider activity data for ClearPoint Neuro, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $MRIC, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.